Related Experiment Videos
[A preliminary study on cytokines in proliferative vitreoretinopathy]
1Department of Ophthalmology, People's Hospital of Beijing Medical University, Beijing 100044.
Insights
Elevated immunoglobulin G (IgG) and complement C3 deposits, along with interleukin-6 (IL-6) and tumor necrosis factor (TNF) cytokines, are linked to proliferative vitreoretinopathy (PVR). These findings suggest a role for immune responses in PVR development.
Area of Science:
- Ophthalmology
- Immunology
- Molecular Biology
Context:
- Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment.
- The pathogenesis of PVR involves complex cellular and molecular events, including inflammation and immune responses.
- Understanding the role of specific cytokines and immune factors is crucial for developing targeted therapies.
Purpose:
- To investigate the involvement of interleukin-6 (IL-6), tumor necrosis factor (TNF), and local immune reactions in the pathogenesis of PVR.
- To quantify immunoglobulin G (IgG) and complement C3 deposits in epiretinal membranes and vitreous samples from PVR patients.
- To assess the levels and biological activity of IL-6 and TNF in the vitreous of PVR eyes.
Summary:
- Immunohistochemistry revealed significantly higher IgG and C3 deposits in epiretinal membranes of PVR eyes compared to controls.
- ELISA detected IL-6 in 13/17 and TNF in 3/11 vitreous samples from PVR patients, while these were absent in normal controls.
- Vitreous IL-6 activity positively correlated with PVR severity, and elevated total vitreous protein (TVP) was also observed in PVR cases.
Impact:
- The presence of IgG, C3, IL-6, and TNF in PVR eyes suggests their significant contribution to the disease's development.
- These findings highlight the potential of targeting immune pathways and cytokines for PVR treatment strategies.
- Further research into the specific mechanisms of immune involvement could lead to novel therapeutic interventions for PVR.
Objective:
To investigate the roles of cytokines like interleukin-6 (IL-6), tumor necrosis factor (TNF) and local immune reaction in proliferative vitreoretinopathy (PVR).
Methods:
Immunohistochemical procedures were applied to identify IgG and complement C(3) deposits in the specimens of epiretinal membranes surgically obtained from patients with PVR. Vitreous aspirates from 33 eyes with idiopathic and traumatic PVR and 8 normal eyes were examined for IgG and complement C(3) by using ELISA; the total vitreous protein (TVP) was determined by Coomassie Brilliant Blue Test; the relative activity of IL-6 in vitreous was tested by means of a proliferative response of IL-6 dependent cells to vitreous samples; and the biological activity of TNF in vitreous was measured with its killing effect on L(929) tumor cells.
Results:
Diffuse deposits of IgG and C(3), TVP in epiretinal membranes of PVR eyes were significantly higher than those in the control group; the activities of IL-6 and TNF (0/8) were not detected in any of the normal control, IL-6 was detected in 13 of 17 vitreous samples and TNF was detected in 3 of 11 vitreous samples from PVR eyes; and vitreous IL-6 activity was found to be positively correlated with the severity of PVR.
Conclusion:
The deposits of IgG and C(3), their elevation in amount and the detection of IL-6 and TNF activity in the vitreous samples from patients with PVR suggest that the cytokines and local immune reaction play a role in the pathogenesis of PVR.